Öztürk E.Yildizli Y.Özsoy E.Gündüz A.2024-08-042024-08-0420211300-1256https://doi.org/10.37845/ret.vit.2021.30.27https://search.trdizin.gov.tr/yayin/detay/505919https://hdl.handle.net/11616/91167Purpose: The aim of this study was to use perfl uorodecalin (PFD) as a short-term postoperative vitreoretinal tamponade and evaluate its effectiveness in retinal detachment. Materials and Methods: This retrospective case series consisted of eight consecutive patients (four female, four male) who presented with retinal detachment (traumatic, secondary to inferior retinal tear, presence of proliferative vitreoretinopathy) at a tertiary university medical center in 2018-2019. All patients underwent pars plana vitrectomy with short-term PFD tamponade. Patients with a minimum follow-up of 3 months were included in the study. The medical charts were analyzed for patient demographics, retinal attachment rates, pre- and postoperative visual acuity, and postoperative complications. Results: The mean duration of PFD tamponade was 16.5 ± 6.3 (range, 7-27) days. The mean follow-up time for the patients was 8.63 ± 2.5 months. The retina was reattached intraoperatively in all patients. In seven patients (87.5%), the retina was still attached throughout follow-up without further vitrectomies. A statistically signifi cant increase was observed when preoperative mean best-corrected visual acuity (BCVA) was compared with mean BCVA in the last follow-up visit (2.9 ± 0.3, 1.3 ± 0.7 logMAR respectively, p=0.018). In seven (87.5%) patients, BCVA improved postoperatively compared with preoperatively. In the postoperative period, pupillary membrane formation was observed in two (25.0%) patients, retrolental membrane in one (12.5%) patient, and epiretinal membrane in one (12.5%) patient. Conclusion: PFD seems to be safe to use as a short-term postoperative vitreoretinal tamponade, and it is useful in retinal detachment. © 2021 Gazi Eye Foundation. All rights reserved.eninfo:eu-repo/semantics/closedAccessPerfl uorodecalinRetinal detachmentVitrectomyVitreoretinal tamponadeReview Article30215816210.37845/ret.vit.2021.30.272-s2.0-85110680470Q4505919